- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Wilson disease
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 512KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 80KB)
Trientine – March 2022
Trientine: Tablet 150 mg (as tetrahydrochloride); Cuprior®
Last updated
1 July 2022